𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Huntington's disease and minocycline

✍ Scribed by Anna K. Hödl; Raphael M. Bonelli

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
44 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A reply to this letter has been published in Movement DisordersMov Disord (2005) 20 (4) 511.

📜 SIMILAR VOLUMES

Reply: Huntington's disease and minocycl
Reply: Huntington's disease and minocycline
✍ Madhavi Thomas; Tetsuo Ashizawa; J. Jankovic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

## Abstract The original letter to which this reply refers was published in __Movement__ DisordersMov Disord (2005) 20 (4) 510–511.

Minocycline in Huntington's disease: A p
Minocycline in Huntington's disease: A pilot study
✍ Madhavi Thomas; Tetsuo Ashizawa; Joseph Jankovic 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

## Abstract Minocycline is a caspase inhibitor, decreases inducible nitric oxide synthase (iNOS), and has been shown to delay disease progression in the mouse model R6/2 of Huntington's disease (HD). This safety and tolerability study included 30 patients with HD who were given minocycline over a 6

A futility study of minocycline in Hunti
A futility study of minocycline in Huntington's disease
✍ Dr. Merit Cudkowicz; The Huntington Study Group DOMINO Investigators 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract This study assessed the futility of proceeding with a Phase 3 clinical trial of minocycline as a disease‐modifying treatment for Huntington's disease (HD). One hundred fourteen research participants with HD were randomized, 87 to minocycline (200 mg/d) and 27 to placebo. The change in T